PR Newswire
WILMINGTON, Del., April 16, 2026
Rising Consumer Preference for Natural Remedies, Surge in Chronic Disease Prevalence, and Expanding Traditional Medicine Systems Drive Global Herbal Medicine Market Growth
WILMINGTON, Del., April 16, 2026 /PRNewswire/ — Allied Market Research has published a new report titled Herbal Medicine Market by Product Type, Drug Type, Application, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2024-2033. According to the report, the global Herbal Medicine Market was valued at $186.4 billion in 2023 and is projected to reach $433.7 billion by 2033, registering a CAGR of 8.8% from 2024 to 2033. The convergence of shifting consumer attitudes toward natural health solutions, a mounting global burden of chronic disease, and increasing institutional recognition of plant-based therapeutics is propelling the Herbal Medicine Market into a new era of sustained, large-scale expansion.
https://mma.prnewswire.com/media/2952079/Allied_Market_Research_Logo.jpg
Herbal medicine also known as botanical medicine or phytotherapy involves using plant-derived substances including leaves, roots, seeds, bark, and flowers to treat a wide range of health conditions. As one of the oldest forms of human medicine, the sector is experiencing a powerful renaissance driven by evolving consumer behavior, the global wellness boom, and growing scientific validation of plant-based therapies.
Request Sample of the Report on Herbal Medicine Market Forecast 2035 – https://www.alliedmarketresearch.com/request-sample/A324087
Market Size & Growth
The global herbal medicine market growth is driven by increasing consumer awareness regarding natural and plant-based therapies. The market has witnessed substantial expansion due to the rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, and arthritis.
In addition, consumers are increasingly shifting toward herbal and organic products as safer alternatives to synthetic drugs, boosting overall market demand. The integration of traditional medicine into modern healthcare systems and rising spending on wellness products are further accelerating growth.
Technological advancements in extraction and formulation techniques have enhanced product quality and efficacy, making herbal medicines more accessible and acceptable globally. Furthermore, the expansion of e-commerce platforms has significantly improved product availability, contributing to the growth of the herbal medicine industry.
Key Market Insights
The Allied Market Research report on the Herbal Medicine Market surfaces the following high-impact findings:
- Market Valuation: The global Herbal Medicine Market size stood at $186.4 billion in 2023 and is projected to reach $433.7 billion by 2033 at a CAGR of 8.8%.
- Product Type Leader: The dietary supplements sub-segment continues to command the largest share within the herbal medicine portfolio, driven by widespread consumer adoption for immunity, digestive health, and metabolic wellness.
- Application Dominance: The pharmaceutical application segment holds the highest revenue contribution, as herbal compounds gain increasing integration into clinical treatment protocols for chronic conditions.
- Distribution Channel: Offline channels including hospital pharmacies, retail pharmacies, and specialty herbal stores account for approximately 68% of total sales, though online channels are recording the fastest CAGR, fueled by surging e-commerce adoption globally.
- Traditional Systems: Ayurveda and Traditional Chinese Medicine (TCM) are the two fastest-growing practice frameworks within the Herbal Medicine Market, benefiting from both cultural resonance and growing international interest.
- Dominant Region: North America leads in revenue contribution, supported by high consumer spending on natural health products and a sophisticated retail infrastructure.
- Fastest-Growing Region: Asia-Pacific is the most dynamic regional market, expected to record the highest CAGR through 2033, powered by the large-scale herbal industries of China and India.
Want to Explore More, Connect to our Analyst – https://www.alliedmarketresearch.com/connect-to-analyst/A324087
Market Segmentation
The herbal medicine market is segmented across multiple dimensions including product type, formulation, source, application, and distribution channel. Key segmentation highlights from the Allied Market Research report include:
By Formulation Type:
Tablets and capsules held the dominant formulation share at 34.2% in 2024, driven by convenience, standardized dosing, and strong physician acceptance within pharmaceutical retail. The liquid and gel segment commands the second-largest position, benefiting from application in herbal drinks, syrups, and cold remedies. Powder formats are gaining traction, particularly for Ayurvedic applications where raw potency and holistic principles like rasa and dosha balancing guide consumer choice. Other formats include syrups, oils, teas, and dried plant extracts.
By Product Type:
The market encompasses Ayurvedic medicines, Traditional Chinese Medicines (TCM), homeopathic products, and aromatherapy. TCM and Ayurveda represent the two largest and fastest-growing traditional medicine segments globally, underpinned by centuries of documented therapeutic practice and increasing institutional support from governments in Asia and beyond.
By Application:
Herbal pharmaceuticals dominate the application landscape. Herbal functional foods, dietary supplements, and herbal beauty and personal care products constitute the fastest-growing application sub-segments. The food & beverages vertical is a major end-user, driven by consumer demand for functional herbal-infused foods, teas, and immunity-boosting beverages. The personal care and beauty segment is expanding rapidly as brands reformulate with natural botanical actives.
By Source:
Plant sources including leaves, roots, barks, fruits, and vegetables form the foundation of herbal medicine sourcing. Supplier diversification and sustainable farming are key sourcing strategies as ingredient traceability becomes a competitive differentiator.
Regional Insights: North America Leads, Asia-Pacific Accelerates
The Allied Market Research herbal medicine market report covers 20 countries across North America, Europe, Asia-Pacific, and LAMEA (Latin America, Middle East & Africa). Regional performance varies significantly, reflecting diverse healthcare infrastructures, regulatory environments, and traditional medicine adoption.
- North America (Largest Market): North America commands the largest revenue share in the global herbal medicine market. The U.S. market alone is valued at approximately $28 billion, driven by robust consumer health consciousness, a rapidly growing natural supplements industry valued at $2+ billion annually, and active research from institutions including Harvard University, Columbia University, and the Memorial Sloan-Kettering Cancer Center into herbal therapeutic applications.
- Europe (High-Value, Mature Market): Europe is a major herbal medicine market accounting for approximately 34-42% of global revenues, with Germany, the UK, France, and Switzerland as primary contributors. Stringent European Medicines Agency (EMA) regulations on herbal medicinal products have created a high-quality, high-trust market. Increasing consumer spending on complementary and alternative medicine (CAM) and regulatory support for traditional medicine therapies sustain consistent market growth.
- Asia-Pacific (Fastest Growing Region): Asia-Pacific represents one of the most dynamic herbal medicine markets, with countries like India, China, Japan, and South Korea at the forefront. India’s Ayurvedic ecosystem led by companies like Patanjali and Himalaya and China’s expansive Traditional Chinese Medicine sector generate enormous domestic and export revenues. Japan’s Kampo system commands a dedicated practitioner and consumer base. Government AYUSH missions and TCM promotion programs continue to catalyze institutional demand.
- LAMEA (Emerging Opportunity): Latin America, the Middle East, and Africa present significant untapped potential. In regions where modern pharmaceutical access remains limited, traditional herbal medicine serves as a primary healthcare modality for over 80% of populations in parts of Africa. Market development is accelerating as brands localize product portfolios and governments invest in traditional medicine documentation and regulation.
For Purchase Related Queries/Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/A324087
Key Players: Competitive Landscape of the Global Herbal Medicine Industry
The global herbal medicine market is characterized by a fragmented yet competitive landscape featuring both multinational corporations and specialized regional players. The following companies are identified as major market participants in the Allied Market Research report:
- Herbalife Nutrition Ltd.
- Himalaya Global Holdings Ltd.
- Patanjali Ayurved Limited
- Dabur Ltd.
- Arkopharma
- Nutraceutical Corporation
- BEOVITA (Beovita Deutschland GmbH & Co. KG)
- Hishimo Pharmaceuticals Pvt. Ltd.
- Schaper & Brümmer GmbH & Co. KG
- Venus Pharma GmbH
- Arizona Natural Products
- NOW Foods
- Nature’s Sunshine Products
- Traditional Medicinals
- Gaia Herbs
These companies are employing a range of strategic initiatives including new product launches, mergers and acquisitions, geographic expansion, licensing agreements, and R&D investment to strengthen their market positioning. Competitive differentiation increasingly hinges on clinical evidence, sustainable sourcing credentials, and digital-first consumer engagement.
Key Recent Industry Developments
The herbal medicine industry continues to witness a flurry of strategic activity underscoring investor confidence and accelerating innovation:
- January 2024: Novartis Launches Sinexia. Swiss pharmaceutical giant Novartis announced the creation of Sinexia, a dedicated business unit for herbal medicines and dietary supplements, signaling a significant entry by Big Pharma into the botanical medicine space.
- March 2024: Dr. Willmar Schwabe & Dabur India Partnership. Germany-based herbal manufacturer Dr. Willmar Schwabe entered a strategic partnership with Dabur India Ltd. to co-develop and commercialize Ayurvedic and herbal products across European and Indian markets.
- April 2024: Yunnan Baiyao Group IPO. Chinese herbal medicine leader Yunnan Baiyao Group raised approximately $500 million through a Hong Kong Stock Exchange IPO, demonstrating strong institutional appetite for herbal medicine equities.
- May 2024: Traditional Medicinals Opens Oregon Facilit. Prominent North American herbal brand Traditional Medicinals inaugurated a state-of-the-art manufacturing facility in Oregon to scale production capacity in response to rising herbal tea and supplement demand.
- June 2024: Dabur Acquires Stake in Kapiva. Dabur India Ltd. acquired a minority stake in fast-growing Indian herbal supplement startup Kapiva, reinforcing its commitment to expanding across the premium herbal wellness segment.
- May 2025: EMA Approves Hanmi Pharmaceutical’s HMPL-523. The European Medicines Agency granted marketing authorization for HMPL-523, an herbal medicine developed by Hanmi Pharmaceutical for treating mild to moderate Alzheimer’s disease marking a landmark event for phytotherapy in neurology.
- April 2025: ACI Ltd. Establishes Herbal Subsidiary in Bangladesh. ACI Ltd. announced the launch of a new subsidiary targeting the quality herbal medicine segment in Bangladesh, reflecting expanding demand across South Asian emerging markets.
Explore AMR’s Extensive Ongoing Coverage on Life Science Industry:
Skincare Market: Global Opportunity Analysis and Industry Forecast, 2023-2032
Medical Cannabis Market: Global Opportunity Analysis and Industry Forecast, 2023-2032
Healthcare Staffing Market: Global Opportunity Analysis and Industry Forecast, 2023-2032
Digital Pathology Market: Global Opportunity Analysis and Industry Forecast, 2023-2032
Health and Wellness Market: Global Opportunity Analysis and Industry Forecast, 2023-2032
AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of «Market Research Reports» and «Business Intelligence Solutions.» AMR has a targeted view to provide business insights and consulting to assist its clients in making strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact
David Correa
1209 Orange Street,Corporation Trust Center,Wilmington, New Castle,Delaware 19801 USA.Toll Free: +1-800-792-5285Int’l: +1-503-894-6022UK: +44-845-528-1300Hong Kong: +852-301-84916India (Pune): +91-20-66346060Fax: [email protected]: https://www.alliedmarketresearch.com
Logo: https://mma.prnewswire.com/media/2952079/Allied_Market_Research_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/herbal-medicine-market-size-to-reach-433-7-billion-by-2033-at-8-8-cagr-reports-allied-market-research-302744711.html
Tengo varias preguntas sobre esto a ver si me podiais aclarar:
-¿Puedo hacer un ingreso regular de 800 euros y me cobran 0euos de comisiones y mto.?
-¿Puedo sacar el dinero cuando quiera?,¿todo ó tengo entendido que hay que mantener un mínimo de 100 euros los 30 meses?
-No necesito pero me obligan a sacar una tarjeta de débito que me cuesta 11 euros el primer año y 22 euros la renovación, también otra de credito que me cuesta 0 euros el primer año y 35 euros la renovación.
¿Hay que mantenerlas 13 meses?
¿Puedo cancelar alguna de ellas desde el principio?
¿Puedo cancelar alguna de ellas antes de la renovación?
¿Hay alguna tarjeta de credito más barata?
Aparte de la cuenta nómina he visto que también que para que te den la tv también se puede sacar una cuenta tarifa plana básica o personal, ¿sabeis algo de estas cuentas?¿que requisitos tienen?
Muchas gracias a todos por responder
Yo fui a informarme y te cuento. Únicamente admiten los ingresos regulares en el caso de que seas autónomo. Te abren una cuenta Tarifa Plana Cero que está exenta de comisiones y presenta alguna ventaja más. Sobre dejar un mínimo de saldo en la cuenta no es necesario, pero sí te obligan a mantener varias tarjetas durante los 30 meses con un coste aproximado de 100 euros anuales.
hola buenas!
me llamo javi y estoy dudando de que banco, me puede dar mas beficios, sin sorpresas por domiciliar la nomina, ya que llevo años en la caixa y no me da nada ningun beneficio. es mas me rechazan los prestamos que solicito, ni siquiera una targeta de credito, por alegan de que siempre esta a cero la cuenta, yo cuando cobro la nomina dejo el dinero para los pagos, y saco el resto, pues no me fio, de que un dia me quede sin dinero, ya que esta todo muy mal, corre riesgo mi dinero o mis ahorros en el banco?? muchas gracias y un cordial saludo.
javi
NO TE EXTRAÑE QUE NO TE DEN LOS PTMOS, PORQUE LO QUE VEN ES QUE NO TIENES CAPACIDAD DE AHORRO PORQUE SIEMPRE DEJAS LA CTA. EN MINIMOS, ASI NINGUN BANCO TE LO VA A CONCEDER. TAMBIEN ES VERDAD QUE LA CAIXA, COMO TANTAS OTRAS CAJAS, TIENE EL PUÑO CERRADO PARA LOS RIESGOS, PARA REMONTAR. NO TE PREOCUPES, QUE POR UNA NOMINA NO CREO QUE NINGUN BANCO SE COJA LAS MANOS. LOS QUE SE TIENEN QUE PREOCUPAR SON LOS QUE TIENEN DÉPÓSITOS Y FONDOS EN BANCOS DE DUDOSA ACTIVIDAD. LA GENTE SE PIENSA QUE PORQUE LES DEN UN 7% YA ES UN GRAN BANCO Y SE EQUIVOCAN. LO QUE LES PASA ES QUE EL BANCO DE ESPAÑA LES PRESTA EL DINERO MAS CARO Y POR ESO OPTAN POR CONSEGUIRLO EN EL MERCADO MONETARIO, Y SI EL BANCO DE ESPAÑA NO SE FIA DE ELLOS, VA Y SE FIA LA GENTE. QUE LOS BANCOS NOES LA ADMON PUBLICA, ABRAN OS OJOS.
Hola , cuando vallais al banco queos dejen lo que hay que pagar de irpf y de iva sobre el valor de la tele ya que en la mayoria de bancos esto no lo dicen y luego llagan las sorpresas .A mi ya me ha pasado con la promoción del portatil y nunca me hablaros de esto . Cuidado
Yo he estado calculando y la tele entre unas cosas y otras te sale sobre unos 250euros que tampoco regalan tanto .Hay oficinas en las que han dado la occión de poner un dinero a plazo fijo a 12meses de 9300euros o 6800euros a 18 meses.
No es ningún chollo. Te obligan a contratar dos tarjetas de crédito que tienes que pagar porque las tienes que mantener 13 meses por lo menos y además llevan unos costes desproporcionados si las utilizas. En total, no usando las tarjetas y anulándolas una vez cumplidos los 13 meses puedes ahorrar unos 38 euros con respecto al precio de ese televisor en una gran superficie. Y además luego vendrá que te cobran para hacienda la retención correspondiente, por lo que probablemente incluso en las mejores condiciones te cueste más que si ahorras un poco y lña compras directamente.
Creó que teneis toda la razón, que aqui no te regalan nada, ya que a mí me paso con unas sartenes que regalaban el banco bilbao, que al final entre el irpf y el descuento de Hacienda, al final me salieron caras, así es que no os tomen el pelo, que al final siempre esta la letra pequeña que es la que nos joroba, por no decir otra cosa.
Yo saque el portatil y ahora me he sacado la TV LCD 32. Estas promos no hay que declararlas. No es obligado domiciliar nomina. Si, meter en la cuenta 800€ todos los meses en un margen de 10 dias. Cero matacero, pero cero,cero, cero de gastos de mantenimiento, ni por recibos, ni por el correo a casa, ni por transfer. Las tarjets gratis el 1er año. Resto fuera. Dadas de baja Menos la de debito. Banesto no pierde nada, ganar, gana clientes que es el proposito de esta promo. Precio de portatil y tv 32 en mercao unos 900€ los 2. En banest 197€. Los hay mejores, nos ha jodio! portatiles a 1200€, TV LCD 32 a 1000€. Señores, son lentejas. Relacion calida-precio-promo es cojonud…….Un saludit a los viandantes.
hola , no se si llegara mi comentario pero os voi a esplicar. esto es el cuento de la abuela. mira yo tengo el portatil. y he cogio tab la tele, pero sabeis ke?, me ha pasado de todo. os esplico. primero me cobran 74 euros y 25 euros de unas tarjetas que yo no las he visto aparecer por mi casa , me cabreo con el banco. llamo y pido esplicaciones. me dicen que van en la promocion, nunca jamas nadie me informo de las tarjetas, no me devuelven el dinero. me cabreo y me dicen que llame aun numero de tefono para darlas de baja, se pasan los dias, intentamos darlas de baja. largas y larga, que si este numero de tefono que si el otro bla bla bla. conseguimos hablar y nos dicen que tenemos que cambiar el contrato a tarifa plana o no se ke historias, llamando al banco se pasan los dias, largas y largas. me cabreo y estoi por suspender todo, me dicen que si lo quiero cambiar y dar de baja las tarjetas que nunca he tenido. tengo que pagar comisiones cada seis meses de doce y pico euros, y que si no quiero que me cobren comisiones tengo que ir todos los meses al banco a hacerlo yo, ufffffffffff.aun hay mas. me dan de baja y me hacen la tarifa plana, se equivocan un monton de veces. me hacen pasar muchos cabreos.y al final cuando llego a casa me han cobrado 25, 50 euros. y llamo por telefono y se lo digo , me dicen claro por dar de baja la otra cuenta , la madre que los pario. ladrones. o sea os digo que la tele no sale regalada, se la cobran y muy bien cobrada , nadie da nada por nada. en cuento termine de pagar lo que debo quito todas las cuentas del banesto.espero que alguien me lea y que me conteste gracias .
Banesto ha jodido a mi marido y a un amigo tambien. Para mi, despues de Banco de Andalucía son los peores. Y quieran creerlo o no ni la television ni el portátil te lo regalan.. como no cumplas cualquiera de las reglas te sancionan con 300 y pico de euros.. porque nos hemos mudado de casa y los recibos domiciados se cortaron «temporalmente» la sancion fue de mas de 300 euros.. y el cabreo q te llevas cuando ves lo q te han descontado y luego para ir a reclamarlos.. y como te tratan !! en fin.. espero que Banesto sea lo primero en undirse en el fin del mundo!!
CHOLLO!!!!!!!!!JAJAJAJAJA…….NO ES NINGUN CHOLLO!!!!!!! te cobran 100 € de gastos de manipulacion, mas 150 € en tarjetas durante 2 años, mas 6 € mensuales de mantenimiento de cuenta durante 30 meses, total que pagas 630 Euros por un ordenador o una TV que su valor seguro que no llega a 500 €. Y encima si vas a cancelar la cuenta cuando cumples los 30 meses requeridos te hacen esperar dos horas para decirte que no tienen linea de telefono para dar de baja la cuenta, cosa que no para nunca cuando vas a contratarlo. Y del trato que dispensan….., es el mismo que si vas con un fajo de billetes de 500 € por los CO-JONES
Banesto «premia», menuda falacia…
No hay ningún banco que premie a nadie.
BANESTO NECESITA NUESTRAS NÓMINAS, Y EN CUANTO VAS UN POCO JUSTO, COMO BUENOS JUDÍOS Y ÁVAROS QUE SON, TE ACOSAN Y MACHACAN, Y TE SACAN HASTA LAS ENTRAÑAS EN COMISIONES.
DESPUÉS EL ESTADO APOYA A LOS BANCOS, CON LA EXCUSA DE QUE SI CAEN LOS BANCOS CAEMOS TODOS. LOS BANCOS NECESITAN UN BOICOT DE VEZ EN CUANDO, PARA QUE NO NOS RESTREGUEN POR LA CARA SUS BENEFICIOS.
POR CIERTO, LO QUE MÁS FASTIDIA A UN BANCO ES UNA RECLAMACIÓN EN LA OFICINA DEL CONSUMIDOR Y OTRA AL BANCO DE ESPAÑA.
ES POR DAR PISTAS…